A.G. de Boer

2.3k total citations
40 papers, 1.9k citations indexed

About

A.G. de Boer is a scholar working on Oncology, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, A.G. de Boer has authored 40 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Pharmaceutical Science and 8 papers in Molecular Biology. Recurrent topics in A.G. de Boer's work include Drug Transport and Resistance Mechanisms (13 papers), Advanced Drug Delivery Systems (9 papers) and Barrier Structure and Function Studies (7 papers). A.G. de Boer is often cited by papers focused on Drug Transport and Resistance Mechanisms (13 papers), Advanced Drug Delivery Systems (9 papers) and Barrier Structure and Function Studies (7 papers). A.G. de Boer collaborates with scholars based in Netherlands, South Africa and United Kingdom. A.G. de Boer's co-authors include D. D. Breimer, Hans E. Junginger, Awie F. Kotzé, H.L. Lueßen, J. Coos Verhoef, J. Coos Verhoef, Maya Thanou, Meindert Danhof, Margret C.M. Blom-Roosemalen and Claus‐Michael Lehr and has published in prestigious journals such as Brain Research, Journal of Controlled Release and Journal of Neurochemistry.

In The Last Decade

A.G. de Boer

40 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.G. de Boer Netherlands 23 799 483 328 244 201 40 1.9k
Junzo Nakamura Japan 24 705 0.9× 890 1.8× 291 0.9× 154 0.6× 82 0.4× 151 2.3k
Nicolaas Schipper Sweden 20 1.6k 2.0× 724 1.5× 119 0.4× 372 1.5× 76 0.4× 30 2.3k
Erik Björk Sweden 32 986 1.2× 531 1.1× 132 0.4× 101 0.4× 79 0.4× 57 2.4k
Maureen D. Donovan United States 23 725 0.9× 409 0.8× 174 0.5× 122 0.5× 76 0.4× 55 1.7k
Remigius U. Agu Canada 19 773 1.0× 359 0.7× 125 0.4× 104 0.4× 75 0.4× 60 1.6k
Fabrizio Bortolotti Italy 24 431 0.5× 504 1.0× 75 0.2× 164 0.7× 41 0.2× 57 1.4k
Takatsuka Yashiki Japan 20 812 1.0× 611 1.3× 134 0.4× 191 0.8× 68 0.3× 45 2.0k
Wenping Zhang China 17 159 0.2× 1.2k 2.6× 220 0.7× 309 1.3× 34 0.2× 78 2.2k
Aditya Reddy Kolli Switzerland 6 146 0.2× 500 1.0× 201 0.6× 111 0.5× 32 0.2× 14 1.7k
Ana Catarina Silva Portugal 27 1.6k 2.1× 1.2k 2.6× 57 0.2× 424 1.7× 52 0.3× 66 3.2k

Countries citing papers authored by A.G. de Boer

Since Specialization
Citations

This map shows the geographic impact of A.G. de Boer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.G. de Boer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.G. de Boer more than expected).

Fields of papers citing papers by A.G. de Boer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.G. de Boer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.G. de Boer. The network helps show where A.G. de Boer may publish in the future.

Co-authorship network of co-authors of A.G. de Boer

This figure shows the co-authorship network connecting the top 25 collaborators of A.G. de Boer. A scholar is included among the top collaborators of A.G. de Boer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.G. de Boer. A.G. de Boer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Islam, Zhahirul, Alex van Belkum, Jaap A. Wagenaar, et al.. (2014). Comparative population structure analysis of Campylobacter jejuni from human and poultry origin in Bangladesh. European Journal of Clinical Microbiology & Infectious Diseases. 33(12). 2173–2181. 12 indexed citations
2.
Sandt, Inez C. J. van der, et al.. (2001). Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood–brain barrier. AIDS. 15(4). 483–491. 97 indexed citations
4.
5.
Kotzé, Awie F., H.L. Lueßen, A.G. de Boer, J. Coos Verhoef, & Hans E. Junginger. (1999). Chitosan for enhanced intestinal permeability: Prospects for derivatives soluble in neutral and basic environments. European Journal of Pharmaceutical Sciences. 7(2). 145–151. 156 indexed citations
7.
Boer, A.G. de & D. D. Breimer. (1998). Chapter 20 Cytokines and blood-brain barrier permeability. Progress in brain research. 115. 425–451. 34 indexed citations
8.
Kotzé, Awie F., Bas J. de Leeuw, H.L. Lueßen, et al.. (1997). Chitosans for enhanced delivery of therapeutic peptides across intestinal epithelia: in vitro evaluation in Caco-2 cell monolayers. International Journal of Pharmaceutics. 159(2). 243–253. 115 indexed citations
9.
Lange, Elizabeth C. M. de, et al.. (1995). The Use of Intracerebral Microdialysis for the Determination of Pharmacokinetic Profiles of Anticancer Drugs in Tumor-Bearing Rat Brain. Pharmaceutical Research. 12(12). 1924–1931. 33 indexed citations
10.
Hoogendoorn, Karin H., Freek J. Zijlstra, Anne‐Marie van Dam, et al.. (1995). Eicosanoid production by rat cerebral endothelial cells: Stimulation by lipopolysaccharide, interleukin-1 and interleukin-6. Journal of Neuroimmunology. 59(1-2). 1–8. 55 indexed citations
11.
Vries, Helga E. de, et al.. (1995). High-density lipoprotein and cerebral endothelial cells in vitro: Interactions and transport. Biochemical Pharmacology. 50(2). 271–273. 30 indexed citations
12.
Jaehde, Ulrich, Rosalinde Masereeuw, A.G. de Boer, et al.. (1994). Quantification and Visualization of the Transport of Octreotide, a Somatostatin Analogue, Across Monolayers of Cerebrovascular Endothelial Cells. Pharmaceutical Research. 11(3). 442–448. 30 indexed citations
13.
Noach, A.B.J., Munetoshi Sakai, Margret C.M. Blom-Roosemalen, et al.. (1994). Effect of anisotonic conditions on the transport of hydrophilic model compounds across monolayers of human colonic cell lines.. Journal of Pharmacology and Experimental Therapeutics. 270(3). 1373–1380. 19 indexed citations
14.
Sakai, Michinori, A.B.J. Noach, Margret C.M. Blom-Roosemalen, A.G. de Boer, & D.D. Breimer. (1994). Absorption enhancement of hydrophilic compounds by verapamil in Caco-2 cell monolayers. Biochemical Pharmacology. 48(6). 1199–1210. 17 indexed citations
16.
Vries, Helga E. de, Johan Kuiper, A.G. de Boer, Th.J.C. van Berkel, & D. D. Breimer. (1993). Characterization of the Scavenger Receptor on Bovine Cerebral Endothelial Cells In Vitro. Journal of Neurochemistry. 61(5). 1813–1821. 22 indexed citations
17.
Stark, Holger, et al.. (1992). In vitro penetration of des-tyrosine1-D-phenylalanine3-β-casomorphin across the blood-brain barrier. Peptides. 13(1). 47–51. 3 indexed citations
18.
Boer, A.G. de, et al.. (1992). Drug transport across the blood — brain barrier. Pharmacy World & Science. 14(6). 338–348. 17 indexed citations
19.
Boer, A.G. de, et al.. (1989). The unit impulse response procedure for the pharmacokinetic evaluation of drug entry into the central nervous system. Journal of Pharmacokinetics and Biopharmaceutics. 17(4). 441–462. 31 indexed citations
20.
Boer, A.G. de, et al.. (1988). Characterization of an "in vitro" blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs.. Journal of Pharmacology and Experimental Therapeutics. 247(3). 1233–1239. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026